Cyclomydril Ophthalmic Solution, 0.2%, 5mL (Cyclopentolate/Phenylephrine)

NDC: 0065-0359-05

Cyclomydril (Cyclopentolate HCl 0.2% / Phenylephrine HCl 1%) Ophthalmic Solution, 5 mL — Alcon

Active ingredients	Cyclopentolate HCl 0.2% and phenylephrine HCl 1%
Dosage form	Ophthalmic solution
Route	Topical ophthalmic
Size	5 mL bottle
Manufacturer	Alcon
NDC	0065-0359-05

Indications and Usage

Indicated for the production of mydriasis (pupil dilation).

Dosage and Administration

Instill one drop in each eye every five to ten minutes as needed. To minimize systemic absorption, apply pressure over the nasolacrimal sac for two to three minutes following instillation.

Warnings and Precautions

• Serious cardiovascular events, including ventricular arrhythmias and myocardial infarction, have been associated with phenylephrine
• May cause CNS disturbances; infants and young children are particularly susceptible to CNS and cardiopulmonary effects
• Use with caution in patients with Down syndrome, elevated temperature, or susceptibility to angle-closure glaucoma
• To avoid inducing angle closure, gauge the anterior chamber angle depth before use

Contraindications

Contraindicated in patients with hypersensitivity to any component of this preparation.

Adverse Reactions

Ocular reactions include increased intraocular pressure, burning, photophobia, and blurred vision; systemic reactions include tachycardia, hypertension, and, particularly in children, psychotic reactions, ataxia, hallucinations, and seizures.

Storage and Handling

Store at 8°C to 25°C (46°F to 77°F).

How Supplied

Sterile ophthalmic solution supplied in a 5 mL plastic DROP-TAINER dispenser.

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.